RCAL
AMGN icon

Rose Capital Advisors LLC’s Amgen AMGN Stock Holding History

Rose Capital Advisors LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Buy
+713
New +$244K 0.13% 92

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Rose Capital Advisors LLC's AMGN Position: Q2 2026 in Review

Rose Capital Advisors LLC opened a new position in Amgen (AMGN) in Q2 2026: 713 shares worth $258K. The stake represents 0.13% of the portfolio and ranks #92 among its holdings.

2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rose Capital Advisors LLC held 713 shares of Amgen worth $258K as of Q2 2026.
  • Amgen was a new Rose Capital Advisors LLC position in Q2 2026.
  • Amgen made up 0.13% of Rose Capital Advisors LLC's portfolio in Q2 2026, its #92 holding.
  • 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rose Capital Advisors LLC's 13F filing for Q2 2026, filed 7 Aug 2026.